These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


PUBMED FOR HANDHELDS

Journal Abstract Search


209 related items for PubMed ID: 21838308

  • 21.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 22. Synthesis and characterization of Fe3O4-PEG-LAC-chitosan-PEI nanoparticle as a survivin siRNA delivery system.
    Arami S, Rashidi MR, Mahdavi M, Fathi M, Entezami AA.
    Hum Exp Toxicol; 2017 Mar; 36(3):227-237. PubMed ID: 27162247
    [Abstract] [Full Text] [Related]

  • 23.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 24.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 25.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 26.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 27.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 28.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 29. Galectin-1 Modulates the Survival and Tumor Necrosis Factor-Related Apoptosis-Inducing Ligand (TRAIL) Sensitivity in Human Hepatocellular Carcinoma Cells.
    Li J, Sun RR, Yu ZJ, Liang H, Shen S, Kan Q.
    Cancer Biother Radiopharm; 2015 Oct; 30(8):336-41. PubMed ID: 26348206
    [Abstract] [Full Text] [Related]

  • 30.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 31. Doxorubicin induces cell death in breast cancer cells regardless of Survivin and XIAP expression levels.
    Nestal de Moraes G, Vasconcelos FC, Delbue D, Mognol GP, Sternberg C, Viola JP, Maia RC.
    Eur J Cell Biol; 2013 Oct; 92(8-9):247-56. PubMed ID: 24064045
    [Abstract] [Full Text] [Related]

  • 32. The combined effect of survivin-targeted shRNA and emodin on the proliferation and invasion of ovarian cancer cells.
    Xue H, Chen Y, Cai X, Zhao L, He A, Guo K, Zheng X.
    Anticancer Drugs; 2013 Oct; 24(9):937-44. PubMed ID: 23921083
    [Abstract] [Full Text] [Related]

  • 33. [RNAi-mediated gene silencing of livin synergistic with epirubicin enhance apoptosis of human breast cancer cells].
    Liang CY, Ma P, Liu XL.
    Zhonghua Yi Xue Za Zhi; 2008 Jun 24; 88(24):1703-6. PubMed ID: 19024543
    [Abstract] [Full Text] [Related]

  • 34. Small interfering RNA-mediated suppression of serum response factor, E2-promotor binding factor and survivin in non-small cell lung cancer cell lines by non-viral transfection.
    Walker T, Nolte A, Steger V, Makowiecki C, Mustafi M, Friedel G, Schlensak C, Wendel HP.
    Eur J Cardiothorac Surg; 2013 Mar 24; 43(3):628-33; discussion 633-4. PubMed ID: 23152437
    [Abstract] [Full Text] [Related]

  • 35. Targeted silencing of Survivin in cancer cells by siRNA loaded chitosan magnetic nanoparticles.
    Unsoy G, Gunduz U.
    Expert Rev Anticancer Ther; 2016 Jul 24; 16(7):789-97. PubMed ID: 27130312
    [Abstract] [Full Text] [Related]

  • 36.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 37.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 38.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 39.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 40. Ultrasound-Guided Delivery of siRNA and a Chemotherapeutic Drug by Using Microbubble Complexes: In Vitro and In Vivo Evaluations in a Prostate Cancer Model.
    Bae YJ, Yoon YI, Yoon TJ, Lee HJ.
    Korean J Radiol; 2016 Jul 24; 17(4):497-508. PubMed ID: 27390541
    [Abstract] [Full Text] [Related]


    Page: [Previous] [Next] [New Search]
    of 11.